Stocktoria

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

OTC · stock · Laboratory Analytical Instruments · website · IPO 2005-10-11

BIOFORCE NANOSCIENCES HOLDINGS, INC. financials (annual)

Revenue
$4500 $16310 $17775 201720182019202020212022202320242025
Net income
-$31261 -$67738 -$46538 -$158.4M -$501955 -$485514 -$471953 -$490437 -$1.3M 201720182019202020212022202320242025
Free cash flow
201720182019202020212022202320242025

Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue——————$17,775$16,310$4,500
Gross profit——————$4,360$4,665$1,255
Operating income——————-$46,538-$66,740-$31,261
Income tax——————$0$0—
Net income-$1.3M-$490,437-$471,953-$485,514-$501,955-$158.4M-$46,538-$67,738-$31,261
EPS (diluted)$-0.04$-0.02$-0.02$-0.02—————
Operating cash flow-$65,150-$61,250-$46,702-$68,389-$77,772-$80,196-$24,383-$62,466-$25,898
Cash & equivalents$786$862$638$734$11,105$39,865$52,895$29,392$14,325
Total assets$786$862$638$734$11,145$39,865$58,895$35,127$20,908
Total liabilities$619,329$2.3M$1.8M$1.3M$873,008$399,773$11,587$5,323$12,706
Shareholders' equity-$618,543-$2.3M-$1.8M-$1.3M-$861,863-$359,908$47,308$29,804$8,202

Growth · year-over-year · Revenue CAGR 98.7%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth——————+9.0%+262.4%—

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.